DIADEM

Diadem was founded in 2012 as a spin-off of University of Brescia (Italy).

Diadem is a pure diagnostic company committed to carry on specific research and development on early peripheral markers of Alzheimer’s disease into technology.

The product s a simple, non-invasive blood test to predict the early onset of Alzheimer’s disease (AD) with the ability to identify mild cognitive impairment (MCI) patients before the clinical symptoms are identifiable 6 years in advance of clinical diagnosis.

AlzoSure® both identifies whether a patient will progress to AD and indicates their current status, such as MCI.